Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Scandion Oncology A/S

SCOL
Current price
0.14 SEK +0.009 SEK (+6.67%)
Last closed 0.13 SEK
ISIN DK0061031895
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 32 484 943 SEK
Yield for 12 month -90.80 %
1Y
3Y
5Y
10Y
15Y
SCOL
21.11.2021 - 28.11.2021

Scandion Oncology A/S, a clinical-stage biotechnology company, discovers and develops medicines for the treatment of cancer. Its lead product candidate is the SCO-101, an oral drug that is in Phase II clinical trial for the treatment of colorectal cancer; and in Phase I clinical trial for treating pancreatic cancer, as well as in preclinical studies for other cancer indications. The company is also developing SCO-201, which is in preclinical trial for the treatment of solid tumors/HIV. The company was incorporated in 2017 and is headquartered in Copenhagen, Denmark. Address: Symbion, Copenhagen, Denmark, 2100

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.07 SEK

P/E ratio

1.0071

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures SCOL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -41 010 986 SEK
Operating Margin TTM 6035.82 %
PE Ratio 1.0071
Return On Assets TTM -52.04 %
PEG Ratio
Return On Equity TTM -86.45 %
Wall Street Target Price 10.07 SEK
Revenue TTM -679 460 SEK
Book Value 0.13 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 2 043 347 SEK
Earnings per share 0.14 SEK
Diluted Eps TTM 0.14 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SCOL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SCOL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation SCOL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 1.0071
Forward PE
Enterprise Value Revenue 1208.6577
Price Sales TTM 233.6545
Enterprise Value EBITDA 0.5567
Price Book MRQ 0.7222

Financials SCOL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SCOL

For 52 weeks

0.12 SEK 5.6 SEK
50 Day MA 0.18 SEK
Shares Short Prior Month
200 Day MA 1.66 SEK
Short Ratio
Shares Short
Short Percent